Liver Metastasis Colon Cancer

SAMe in Prevention of Oxaliplatin-associated Liver Injury

GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer

Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens

Living Donor Liver Transplantation for CRC Liver Metastases

Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard Systemic Treatment

Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases

Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing

Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease

LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis

Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer

Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors

I-FIGS Feasibility Study

Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases

On-treatment Biomarkers in Metastatic Colorectal Cancer for Life

Gadoxetate Abbreviated MRI in Metastatic Colorectal Cancer

Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM

SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases